Prevalence of Carbapenem-Resistant Enterobacteriaceae in Western Saudi Arabia and Increasing Trends in the Antimicrobial Resistance of Enterobacteriaceae.
blaimp
blandm
blaoxa-48
blavim
carbapenemase
e. coli.
k. pneumoniae
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
accepted:
15
02
2023
entrez:
21
3
2023
pubmed:
22
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
The aim of the study is to estimate the prevalence rate of carbapenem-resistant Enterobacteriaceae (CRE) and to determine the types of carbapenemase genes present in patients admitted to King Abdulaziz Medical City (KAMC-J) and King Abdulaziz University Hospital (KAUH), both in Jeddah, Saudi Arabia. A total of 180 isolates were analyzed which were included on the basis of retrospective chart review of patients from KAMC-J and KAUH between 1 During the study period, the prevalence of CRE considerably rose in the two tertiary care institutions from western Saudi Arabia. In the CRE isolates,
Identifiants
pubmed: 36942194
doi: 10.7759/cureus.35050
pmc: PMC10024340
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e35050Informations de copyright
Copyright © 2023, Taha et al.
Déclaration de conflit d'intérêts
This article was previously posted to the research square preprint server on 26 Aug, 2020, however the authors have requested that this preprint be removed from Research Square.
Références
Front Microbiol. 2020 May 28;11:936
pubmed: 32547503
Antimicrob Resist Infect Control. 2019 Dec 19;8:203
pubmed: 31890159
J Intern Med. 2015 May;277(5):501-12
pubmed: 25556628
J Infect Dev Ctries. 2019 Feb 28;13(2):162-164
pubmed: 32036352
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
pubmed: 17630334
J Clin Microbiol. 2018 Oct 25;56(11):
pubmed: 30158194
Pharmacotherapy. 2003 Oct;23(10):1232-7
pubmed: 14594340
J Glob Infect Dis. 2016 Jan-Mar;8(1):41-50
pubmed: 27013843
Int J Antimicrob Agents. 2013 May;41(5):463-7
pubmed: 23537581
Med Sci (Basel). 2017 Dec 21;6(1):
pubmed: 29267233
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30104282
Antimicrob Resist Infect Control. 2012 Jul 19;1(1):26
pubmed: 22958584
Am J Infect Control. 2016 Feb;44(2):126-30
pubmed: 26631643
Clin Microbiol Rev. 2019 Jan 30;32(2):
pubmed: 30700432
Ann Saudi Med. 2005 May-Jun;25(3):239-42
pubmed: 16119526
PLoS One. 2015 Jun 25;10(6):e0131372
pubmed: 26110660
Biomed Res Int. 2019 Apr 23;2019:9757625
pubmed: 31179337
J Infect Public Health. 2019 Jul - Aug;12(4):465-471
pubmed: 31060974
BMC Infect Dis. 2017 Oct 10;17(1):666
pubmed: 29017452
Emerg Infect Dis. 2015 Sep;21(9):1611-6
pubmed: 26290955
BMC Microbiol. 2017 Apr 27;17(1):101
pubmed: 28449650
Am J Infect Control. 2006 Jun;34(5 Suppl 1):S20-8; discussion S64-73
pubmed: 16813978
Drug Resist Updat. 2016 Nov;29:30-46
pubmed: 27912842
Saudi Med J. 2018 Jan;39(1):23-30
pubmed: 29332105
Mayo Clin Proc. 2011 Mar;86(3):250-9
pubmed: 21364117
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630191
Chin Med J (Engl). 2015 Jul 20;128(14):1969-76
pubmed: 26168840
Antimicrob Agents Chemother. 2014 Jun;58(6):3085-90
pubmed: 24637692
Lancet Infect Dis. 2017 Feb;17(2):153-163
pubmed: 27866944